UnitedHealth Group reported third-quarter earnings that exceeded Wall Street expectations, leading the company to increase its full-year profit forecast. The insurer, the largest private healthcare provider in the U.S., posted adjusted earnings per share of $4.69 versus the $4.14 analysts had predicted. Its revenue came in at $112.69 billion, slightly above the anticipated $111.4 billion. This marks the company's third consecutive quarter of strong financial performance in 2026, supported by efforts to streamline operations and strengthen its business model.

Despite ongoing challenges with elevated medical costs, UnitedHealth has made significant progress through initiatives focusing on value-based care and the use of artificial intelligence. CFO Wayne DeVeydt highlighted the company's strategy of shifting doctor and facility compensation toward better patient outcomes and cost efficiency, rather than the volume of services. This approach has contributed to a lower medical cost ratio of 88.4% for the quarter, better than the 89.9% estimated by analysts, signaling improved cost management amid persistent upward pressure on healthcare expenses.

UnitedHealth is also navigating complexities from federal regulations such as the No Surprises Act, which has increased medical claims costs through its independent dispute resolution process. Specialty pharmacy drugs and inpatient services remain costly areas, but the insurer’s focus on steering patients to lower-cost care venues has helped curb expenses. Data showed a 15% year-over-year decrease in acute hospital admissions and a 10% increase in home health admissions, reflecting a shift toward more cost-effective and patient-preferred care settings.

Looking ahead, UnitedHealth plans to expand its investments in AI-powered solutions designed to reduce administrative burdens on physicians, such as ambient listening tools and enhanced appointment scheduling capabilities. These technology-driven efficiencies are expected to reinforce the company’s ability to manage medical costs and improve patient care throughout the remainder of 2026 and into 2027. With these measures gaining traction, UnitedHealth raised its fiscal 2026 adjusted earnings guidance to at least $20.50 per share, up from the prior range of $19.50 to $20.